Physician

Keith Mark Gross, MD

According to 2025 Medicare claims, Keith Gross, MD (NPI: 1952357188) practices dermatology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is KEITH MARK GROSS MD INC (NPI: 1871658278; TIN: 954748863) and primary practice location at 85367-7847.

Gross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,108 traditional Medicare patients, billed 24,278 HCPCS/CPT codes, and received $1,395,751 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,176 prescription claims across 711 beneficiaries totaling $17,714 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $95,689 to $17,714. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,282	36,007	$1,484,328
2016	3,436	35,958	$1,455,810
2017	3,411	39,883	$1,609,537
2018	3,181	37,219	$1,586,629
2019	3,133	36,789	$1,601,475
2020	2,247	22,171	$1,076,434
2021	2,450	21,973	$1,301,660
2022	2,732	24,975	$1,379,762
2023	3,079	24,822	$1,449,386
2024	3,108	24,278	$1,395,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	878	1,775	$95,689
2016	854	1,599	$76,244
2017	770	1,445	$59,490
2018	840	1,608	$58,022
2019	872	1,649	$46,227
2020	558	1,142	$33,879
2021	681	1,169	$21,209
2022	667	1,184	$22,683
2023	748	1,240	$22,977
2024	711	1,176	$17,714

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	991	1,271	$64
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	600	801	$43
17000	Destruction of precancer skin growth, 1 growth	1,034	1,778	$37
88305	Pathology examination of tissue using a microscope, intermediate complexity	2,574	6,900	$30
17003	Destruction of precancer skin growth, 2-14 growths	827	7,659	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	36	1,007	$2,181
Mometasone Furoate	Mometasone Furoate	91	2,372	$1,879
Metronidazole	Metronidazole	29	797	$1,680
Betamethasone Dipropionate	Betamethasone Dipropionate	40	1,092	$1,561
Cephalexin	Cephalexin	480	2,619	$1,509

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Keith Mark Gross, MD?

Tedicare shows public-source Medicare data for Keith Mark Gross, MD (NPI 1952357188), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keith Mark Gross, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Keith Mark Gross, MD?

Keith Mark Gross, MD is linked to KEITH MARK GROSS MD INC (billing NPI 1871658278) in the available physician profile data.

Does Keith Mark Gross, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.